Pazopanib

본문 바로가기


Home > Product > Pazopanib
Selling leads
Pazopanib
Posting date : Jun 30, 2025
Membership
Free Member Scince Jun 27, 2025
FOB Price
detailed discussion
Min. Order Quantity
1
Supply Abillity
hundreds of kgs
Port
Shanghai Port
Payment Terms
detailed discussion
Package
Convenient package
Keyword :
Category
Contact
Lena
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Royal
Model Number
+86 15242851296
HS-CODE
-
Package & Delivery Lead Time
Package
Convenient package
Detailed Description

Pazopanib is a novel oral angiogenesis inhibitor developed by GlaxoSmithKline that can interfere with the formation of new blood vessels necessary for the survival and growth of stubborn tumors. It targets the vascular endothelial growth factor receptor (VEGFR) and works by inhibiting the formation of new blood vessels that supply blood to tumors. It is applicable for the treatment of advanced renal cell carcinoma (a type of renal cancer in which cancer cells are found in the renal tubules), soft tissue sarcoma (STS), epithelial ovarian cancer and non-small cell lung cancer (NSCLC).


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top